Asundexian

An arrow incrementally going up stairs before pointing straight up Blue background

Racing BMS and J&J, Bayer ties asundexian to 26% stroke decrease

The readout sets the bar for Bristol Myers Squibb and Johnson & Johnson in a blockbuster indication ahead of data on their rival factor XIa inhibitor.

Nick Paul Taylor Feb 5, 2026 12:15pm

Falling Rocks Warning and danger Road Sign with rock background

New data show how Bayer's asundexian failed to prevent strokes

Sep 1, 2024 3:40am

Human heart with ecg graph - stock photo Rasi BhadramaniGetty Images

Bayer's blood thinner fails phase 3, denting $5B sales forecast

Nov 20, 2023 5:00am

Bayer, like its rivals, flops ph. 2 but hopes it made a splash

Aug 29, 2022 10:30am